Invention Grant
- Patent Title: Viral chemokine-antigen fusion proteins
- Patent Title (中): 病毒趋化因子 - 抗原融合蛋白
-
Application No.: US13541997Application Date: 2012-07-05
-
Publication No.: US08460675B2Publication Date: 2013-06-11
- Inventor: Larry W. Kwak , Bira Arya
- Applicant: Larry W. Kwak , Bira Arya
- Applicant Address: US DC Washington
- Assignee: The United States of America, as represented by the Secretary, Department of the Health and Human Services
- Current Assignee: The United States of America, as represented by the Secretary, Department of the Health and Human Services
- Current Assignee Address: US DC Washington
- Agency: Klarquist Sparkman, LLP
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K38/00 ; A61K45/00 ; A61K39/00 ; A61K31/00 ; C08H1/00
Abstract:
The present invention relates to a vaccine for increasing the immunogenicity of a tumor antigen thus allowing treatment of cancer, as well as a vaccine that increases the immunogenicity of a viral antigen, thus allowing treatment of viral infection, including immunodeficiency virus (HIV) infection. In particular, the present invention provides a fusion protein comprising a viral chemokine fused to either a tumor antigen or viral antigen which is administered as either a protein or nucleic acid vaccine to elicit an immune response effective in treating cancer or effective in treating or preventing viral infection.
Public/Granted literature
- US20120276101A1 VIRAL CHEMOKINE-ANTIGEN FUSION PROTEINS Public/Granted day:2012-11-01
Information query
